by BioSpace Insights –
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
With the cell and gene therapies (CGTs) sector facing multiple challenges even as it celebrates successes, there was plenty for experts to discuss at the 2025 Cell & Gene Therapy Summit. Hosted by Charles River Laboratories, the March 4 event featured several sessions, including “Industry Updates on Advanced Therapeutics 2025” and “Investor and Market Insights.”
